{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:01:18Z","timestamp":1760266878210,"version":"3.40.4"},"reference-count":30,"publisher":"S. Karger AG","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Onkologie"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1159\/000122029","type":"journal-article","created":{"date-parts":[[2008,5,16]],"date-time":"2008-05-16T12:10:54Z","timestamp":1210939854000},"page":"237-241","source":"Crossref","is-referenced-by-count":10,"title":["Gefitinib in Combination with Oxaliplatin and 5-Fluorouracil in Irinotecan-Refractory Patients with Colorectal Cancer: A Phase I Study of the Arbeits gemeinschaft Internistische Onkologie (AIO)"],"prefix":"10.1159","volume":"31","author":[{"given":"J&ouml;rg Thomas","family":"Hartmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Peter","family":"Pintoffl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik","family":"Kr&ouml;ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Bokemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Holtmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"H&ouml;hler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","reference":[{"doi-asserted-by":"publisher","key":"p_1_88","DOI":"10.1200\/JCO.2005.03.0106"},{"key":"p_2_89","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","volume":"18","author":"de Gramont A","year":"2000","journal-title":"J Clin Oncol"},{"doi-asserted-by":"publisher","key":"p_3_90","DOI":"10.1200\/JCO.2004.05.113"},{"doi-asserted-by":"publisher","key":"p_4_91","DOI":"10.1200\/JCO.2005.05.546"},{"doi-asserted-by":"publisher","key":"p_5_92","DOI":"10.1200\/JCO.2005.10.017"},{"doi-asserted-by":"publisher","key":"p_6_93","DOI":"10.1056\/NEJMoa033025"},{"doi-asserted-by":"publisher","key":"p_7_94","DOI":"10.1002\/1097-0142(19930415)71:8<2454::AID-CNCR2820710805>3.0.CO;2-2"},{"doi-asserted-by":"publisher","key":"p_8_95","DOI":"10.1002\/cncr.11152"},{"doi-asserted-by":"publisher","key":"p_9_96","DOI":"10.1016\/1040-8428(94)00144-I"},{"doi-asserted-by":"publisher","key":"p_10_97","DOI":"10.1159\/000030116"},{"doi-asserted-by":"publisher","key":"p_11_98","DOI":"10.1200\/JCO.2005.09.112"},{"doi-asserted-by":"publisher","key":"p_12_99","DOI":"10.1158\/0008-5472.CAN-06-1000"},{"doi-asserted-by":"publisher","key":"p_13_100","DOI":"10.1200\/JCO.2005.03.0536"},{"key":"p_14_101","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3816\/CCC.2006.n.037","volume":"6","author":"Wolpin BM","year":"2006","journal-title":"Clin Colorectal Cancer"},{"key":"p_15_102","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1200\/JCO.1998.16.9.3169","volume":"16","author":"Wadler S","year":"1998","journal-title":"J Clin Oncol"},{"doi-asserted-by":"publisher","key":"p_16_103","DOI":"10.1093\/jnci\/92.3.205"},{"doi-asserted-by":"publisher","key":"p_17_104","DOI":"10.2307\/2281868"},{"doi-asserted-by":"publisher","key":"p_18_105","DOI":"10.1126\/science.1101637"},{"doi-asserted-by":"publisher","key":"p_19_106","DOI":"10.1200\/JCO.2005.08.037"},{"doi-asserted-by":"publisher","key":"p_20_107","DOI":"10.1200\/JCO.2004.10.182"},{"doi-asserted-by":"publisher","key":"p_21_108","DOI":"10.1200\/JCO.2006.08.1620"},{"doi-asserted-by":"publisher","key":"p_22_109","DOI":"10.1158\/1078-0432.CCR-05-0738"},{"doi-asserted-by":"publisher","key":"p_23_110","DOI":"10.1093\/annonc\/mdi356"},{"doi-asserted-by":"publisher","key":"p_24_111","DOI":"10.1158\/1078-0432.CCR-04-1894"},{"doi-asserted-by":"publisher","key":"p_25_112","DOI":"10.1056\/NEJM200412303512724"},{"doi-asserted-by":"publisher","key":"p_26_113","DOI":"10.1056\/NEJM200507143530218"},{"doi-asserted-by":"crossref","unstructured":"Xu JM, Azzariti A, Colucci G, Paradiso A: The effect of gefitinib (Iressa, ZD1839) in combination with oxaliplatin is schedule-dependent in colon cancer cell lines. Cancer Chemother Pharmacol 2003;52:442-448.","key":"p_27_114","DOI":"10.1007\/s00280-003-0687-8"},{"doi-asserted-by":"publisher","key":"p_28_115","DOI":"10.1016\/S0006-2952(03)00291-0"},{"doi-asserted-by":"publisher","key":"p_29_116","DOI":"10.1159\/000087344"},{"doi-asserted-by":"publisher","key":"p_30_117","DOI":"10.1200\/JCO.2005.08.359"}],"container-title":["Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.karger.com\/Article\/Pdf\/122029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T02:10:19Z","timestamp":1745460619000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000122029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1159\/000122029","relation":{},"ISSN":["1423-0240","0378-584X"],"issn-type":[{"type":"electronic","value":"1423-0240"},{"type":"print","value":"0378-584X"}],"subject":[],"published":{"date-parts":[[2008]]}}}